MedTrace Logo

A Multicenter, Prospective, Observational Study With PriMatrix for the Treatment of Neuropathic Diabetic Foot Ulcers

NCT01228526 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2016-08-26

No results posted yet for this study

Summary

To evaluate the effectiveness of PriMatrix in the treatment of DFUs in subjects without significantly compromised arterial circulation.

Conditions

  • Foot Ulcers, Diabetic

Interventions

DEVICE

PriMatrix

Sponsors & Collaborators

  • Mayo Clinic

    collaborator OTHER

  • Samuel Merritt University

    collaborator OTHER

  • New York College of Podiatric Medicine

    collaborator OTHER

  • Temple University

    collaborator OTHER

  • Circleville Foot & Ankle LLC

    collaborator UNKNOWN

  • Integra LifeSciences Corporation

    lead INDUSTRY

Principal Investigators

  • Steven Kavros, DPM · Mayo Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2012-09-30
Completion
2012-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01228526 on ClinicalTrials.gov